Neuroimaging Genetics of PTSD

PTSD 的神经影像遗传学

基本信息

批准号：
8636651
负责人：
MARK W MILLER
金额：
$ 19.64万
依托单位：
BOSTON UNIVERSITY MEDICAL CAMPUS
依托单位国家：
美国
项目类别：
财政年份：
2014
资助国家：
美国
起止时间：
2014-02-01 至 2016-01-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8636651
关键词：
Affect Attention Boston Brain Brain region Brain scan Candidate Disease Gene Caucasians Caucasoid Race Center for Translational Science Activities Data Development Diagnostic Dimensions Disease Distress Emotions Event Fright Future Gene Chips Genes Genetic Genetic Risk Genomics Genotype Glucocorticoids Healthcare Systems Heritability Individual Individual Differences Inflammation Light Location Longevity Magnetic Resonance Imaging Measures Memory Mental Health Military Personnel Molecular Genetics Natural Disasters Nerve Degeneration Neurons Orphan Oxidative Stress Personal Communication Pharmaceutical Preparations Play Population Post-Traumatic Stress Disorders Prevalence Process Psychopathology Publishing Recording of previous events Regulation Research Research Personnel Resolution Risk Role Serotonin Severities Survivors Symptoms System Terrorism Testing Thick Trauma Traumatic Brain Injury Tretinoin Twin Studies Variant Veterans Violence War base brain cell brain morphology cell injury combat density design disorder risk gene function genetic association genetic variant genome wide association study interest neural circuit neuroimaging public health priorities public health relevance receptor relating to nervous system resilience response risk variant stress disorder white matter

项目摘要

DESCRIPTION (provided by applicant): With terrorism, natural disasters, mass shootings, war and other forms of horror and violence on the rise across the globe, understanding the mental health consequences of these events, and treating survivors, has become a major public health priority. Posttraumatic stress disorder (PTSD) is the most common psychiatric consequence for survivors of such trauma and a serious and potentially disabling condition that affects 8-10% of individuals in the U.S. population at some point during their lifetimes (Kessler et al., 2012; Kessler et al., 1995). In those exposed to intense and repeated trauma, such as military combat, lifetime prevalence is considerably higher (i.e., closer to 20%). Twin studies have shown that a substantial proportion of variation in PTSD risk is attributable to hereditable factors leading investigators to begin to explore the molecular genetic basis of these effects. Unfortunately, results of genetic association studies conducted to date have been inconsistent and the heritability of PTSD remains largely unexplained. Recently, however, our research group published the first genome-wide association study (GWAS) of PTSD which implicated the Retinoic Acid Orphan Receptor Alpha gene (RORA) as a significant risk locus for the development of PTSD after trauma exposure (Logue et al., 2012). The primary finding from that study was subsequently replicated by an independent research group (Amstadter et al., 2013). We believe that the basis for RORA's association with PTSD lies in its role in protecting neurons from the effects of oxidative stress (OXS) and inflammation (INF). Specifically, we hypothesize that individuals who carry the RORA risk variant(s) have a reduced capacity to mount a neuroprotective response to the OXS and INF associated with PTSD. As a result, they are more likely to incur damage to regions of the brain involved in emotion, memory, attention, and other psychiatrically-relevant processes where the loss of neural integrity alters brain function and yields symptoms of the disorder. The primary aim of this study is to test this and related hypotheses using data from the Translational Research Center for Traumatic Brain Injury and Stress Disorders at VA Boston Healthcare System (TRACTS). Specifically, we propose to study the intersection of RORA genotype, other OXS and INF genes, PTSD and other psychopathology, and structural brain parameters using existing genomic data from a high-density gene chip and high resolution structural magnetic resonance imaging (MRI) brain scans from 190 Caucasian OEF/OIF veterans. We will also explore associations between other aspects of psychiatric illness and abnormalities in brain morphology and examine effects of mild Traumatic Brain Injury (mTBI) on these parameters. Evidence in support of our primary hypotheses could pave the way towards the development of medications designed to enhance protective RORA and OXS and INF gene function-and in doing so promote neural resilience in individuals with genetic risk variants.

描述（由申请人提供）：随着恐怖主义、自然灾害、大规模枪击事件、战争和其他形式的恐怖和暴力在全球范围内不断增加，了解这些事件的心理健康后果并治疗幸存者已成为一项主要的公共卫生问题优先事项。创伤后应激障碍 (PTSD) 是此类创伤幸存者最常见的精神后果，也是一种严重且可能致残的疾病，在一生中的某个时刻影响着 8-10% 的美国人（Kessler 等，2012；凯斯勒等人，1995）。在那些遭受严重和反复创伤（例如军事战斗）的人中，终生患病率要高得多（即接近 20%）。双胞胎研究表明，PTSD 风险的很大一部分变异可归因于遗传因素，这促使研究人员开始探索这些影响的分子遗传基础。不幸的是，迄今为止进行的遗传关联研究的结果并不一致，创伤后应激障碍的遗传性在很大程度上仍然无法解释。然而，最近，我们的研究小组发表了第一个关于 PTSD 的全基因组关联研究 (GWAS)，该研究表明视黄酸孤儿受体 Alpha 基因 (RORA) 是创伤暴露后发生 PTSD 的一个重要风险位点 (Logue 等，2017)。，2012）。该研究的主要发现随后被一个独立研究小组复制（Amstadter 等，2013）。我们认为，RORA 与 PTSD 相关的基础在于它在保护神经元免受氧化应激 (OXS) 和炎症 (INF) 影响方面的作用。具体来说，我们假设携带 RORA 风险变异的个体对与 PTSD 相关的 OXS 和 INF 产生神经保护反应的能力较低。因此，他们更有可能对涉及情绪、记忆、注意力和其他精神相关过程的大脑区域造成损害，在这些区域中，神经完整性的丧失会改变大脑功能并产生疾病症状。本研究的主要目的是使用来自 VA 波士顿医疗系统 (TRACTS) 创伤性脑损伤和应激障碍转化研究中心的数据来测试这一假设和相关假设。具体来说，我们建议使用来自高密度基因芯片和高分辨率结构磁共振成像 (MRI) 脑扫描的现有基因组数据来研究 RORA 基因型、其他 OXS 和 INF 基因、PTSD 和其他精神病理学以及结构脑参数的交叉点来自 190 名白人 OEF/OIF 退伍军人。我们还将探讨精神疾病其他方面与大脑形态异常之间的关联，并检查轻度创伤性脑损伤 (mTBI) 对这些参数的影响。支持我们主要假设的证据可以为开发旨在增强保护性 RORA、OXS 和 INF 基因功能的药物铺平道路，从而促进具有遗传风险变异的个体的神经恢复能力。